ClassID:

20918

A61K38/1709 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#1201
20210147556
2021-05-20

Methods of inhibiting integrin α9β1 activity

#1202
20210147535
2021-05-20

Oligonucleotides for reduction of PD-L1 expression

#1203
20210146012
2021-05-20

HUMAN SKIN EQUIVALENTS EXPRESSING EXOGENOUS POLYPEPTIDES

#1204
20210145973
2021-05-20

Phosphorothioate-conjugated peptides and methods of using the same

#1205
20210145934
2021-05-20

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#1206
20210145933
2021-05-20

C3B binding polypeptide

#1207
20210145932
2021-05-20

APOMERS

#1208
20210145890
2021-05-20

DYSTROPHIN GLYCOPROTEIN COMPLEX SEQUESTERS YAP TO INHIBIT CARDIOMYOCYTE PROLIFERATION

#1209
20210139997
2021-05-13

Treatment of angiogenesis disorders

#1210
20210139562
2021-05-13

Removal of serine proteases by treatment with finely divided silicon dioxide

#1211
20210138034
2021-05-13

TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS

#1212
20210138033
2021-05-13

NNIF and nNIF-related peptides and related methods

#1213
20210137875
2021-05-13

TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM

#1214
20210137811
2021-05-13

TRPV3 agonists for the treatment of skin conditions

#1215
20210130427
2021-05-06

Production of recombinant lubricin

#1216
20210130423
2021-05-06

COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE INGREDIENT

#1217
20210128683
2021-05-06

PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING RESISTANCE DUE TO CANCER CHEMOTHERAPY AND ENHANCING EFFECT OF CANCER CHEMOTHERAPY

#1218
20210128682
2021-05-06

Formulations and methods of use for alpha connexin c-terminal (ACT) peptides

#1219
20210128681
2021-05-06

Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein

#1220
20210128663
2021-05-06

Compositions and methods to improve exercise performance and recovery

#1221
20210128637
2021-05-06

Methods for treating cardiac conditions

#1222
20210122796
2021-04-29

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

#1223
20210121523
2021-04-29

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

#1224
20210121522
2021-04-29

MIXED-LINEAGE KINASE DOMAIN-LIKE PROTEIN IN IMMUNOTHERAPEUTIC CANCER CONTROL

#1225
20210113657
2021-04-22

GLA DOMAINS AS TARGETING AGENTS

#1226
20210113655
2021-04-22

Polypeptide-polymer conjugates and methods of use thereof

#1227
20210113483
2021-04-22

Cationic polymers

#1228
20210113471
2021-04-22

Annelid haemoglobin lyophilisation process

#1229
20210106727
2021-04-15

Nanofibrous scaffolds to heal chronic skin wounds

#1230
20210106654
2021-04-15

Methods of treating cognitive impairment

#1231
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

#1232
20210106527
2021-04-15

Compositions, methods and uses of messenger RNA

#1233
20210102945
2021-04-08

Saposin-A derived peptides and uses thereof

#1234
20210102208
2021-04-08

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

#1235
20210100918
2021-04-08

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

#1236
20210100881
2021-04-08

Methods for diagnosing and treating Alzheimer's disease

#1237
20210094998
2021-04-01

Immunoglobulins and uses thereof

#1238
20210093749
2021-04-01

Bioactive polymer for bone regeneration

#1239
20210093695
2021-04-01

Method

#1240
20210093694
2021-04-01

Polypeptide for use in the protection of oxygen sensitive gram-positive bacteria

#1241
20210093565
2021-04-01

VESICLE-ENCAPSULATED SOCS

#1242
20210087585
2021-03-25

TRANSDUCTION BUFFER

#1243
20210087247
2021-03-25

MPS PEPTIDES AND USE THEREOF

#1244
20210087245
2021-03-25

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

#1245
20210087242
2021-03-25

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#1246
20210085803
2021-03-25

METHOD FOR OPENING TIGHT JUNCTIONS

#1247
20210085797
2021-03-25

TOPICAL DELIVERY OF THERAPEUTIC AGENTS USING CELL-PENETRATING PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES

#1248
20210085624
2021-03-25

COMPOSITIONS AND METHODS USING A COMBINATION OF AUTOPHAGY INDUCER AND HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY

#1249
20210079079
2021-03-18

SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING

#1250
20210077620
2021-03-18

Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use

#1251
20210077552
2021-03-18

MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF

#1252
20210070838
2021-03-11

Constructs having a SIRP-alpha domain or variant thereof

#1253
20210069301
2021-03-11

Target for diabetes treatment and prevention

#1254
20210069296
2021-03-11

Treatment of pyroptosis

#1255
20210069294
2021-03-11

Serum response factor regenerates senescent cells

#1256
20210069293
2021-03-11

MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION

#1257
20210062263
2021-03-04

A CLINICAL MANAGEMENT PROTOCOL

#1258
20210060124
2021-03-04

Methods and compositions for treating Huntington's Disease

#1259
20210060122
2021-03-04

Method for treating cerebral stroke

#1260
20210052656
2021-02-25

Processes for making and using a mesenchymal stem cell derived secretome

#1261
20210052496
2021-02-25

Anionic nanocomplexes for nucleic acid delivery

#1262
20210047656
2021-02-18

VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

#1263
20210047378
2021-02-18

Materials and methods for treating Friedreich's Ataxia

#1264
20210047374
2021-02-18

Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum

#1265
20210046157
2021-02-18

Macrophage stimulating 1 receptor (MST1R) variants and uses thereof

#1266
20210046156
2021-02-18

ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES

#1267
20210038693
2021-02-11

Heparin-Associated Polypeptides and Uses Thereof

#1268
20210038686
2021-02-11

Mutant NGAL proteins and uses thereof

#1269
20210038653
2021-02-11

METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#1270
20210032338
2021-02-04

Materials and methods for modulating t cell mediated immunity

#1271
20210024895
2021-01-28

RNA preparations comprising purified modified RNA for reprogramming cells

#1272
20210023172
2021-01-28

Administering methylation-controlled J protein (MCJ) SIRNA to a kidney cell

#1273
20210023171
2021-01-28

Peptides and related compositions and methods

#1274
20210023160
2021-01-28

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

#1275
20210018518
2021-01-21

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

#1276
20210017243
2021-01-21

METHOD FOR PRODUCING COMPOSITION CONTAINING K-CASEIN GLYCOMACROPEPTIDE

#1277
20210015900
2021-01-21

GLA DOMAINS AS THERAPEUTIC AGENTS

#1278
20210015758
2021-01-21

Modular Particulars for Immunotherapy

#1279
20210009657
2021-01-14

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS

#1280
20210009648
2021-01-14

PEPTIDES FOR TREATMENT OF DIABETES

#1281
20210009510
2021-01-14

CHELATING MOLECULES

#1282
20210008161
2021-01-14

METHODS AND COMPOSITIONS FOR IMPROVED HOMOLOGY DIRECTED REPAIR

#1283
20210007987
2021-01-14

Wnt compositions and methods for purification

#1284
20210002336
2021-01-07

Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

#1285
20210002328
2021-01-07

Peptide therapies for reduction of macular thickening

#1286
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

#1287
20210000964
2021-01-07

Fatty acids and their use in conjugation to biomolecules

#1288
20210000916
2021-01-07

Composition comprising poly I:C and LAG-3-IGG fusion protein

#1289
20210000885
2021-01-07

Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being

#1290
20210000883
2021-01-07

Method and system for reducing the likelihood of osteoporosis

#1291
20210000879
2021-01-07

METHODS AND COMPOSITIONS FOR MRNA-BASED MODULATION AND DETECTION OF CELL PHENOTYPES

#1292
20210000855
2021-01-07

RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION

#1293
20200407453
2020-12-31

A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN

#1294
20200407415
2020-12-31

Activin receptor type IIB variants and methods of use thereof

#1295
20200405809
2020-12-31

COMBINATION OF A CYCLIN DEPENDENT KINASE INHIBITOR AND A BET- BROMODOMAIN INHIBITOR

#1296
20200405773
2020-12-31

PROMOTING AND PROTECTING FUNCTIONAL BETA CELL MASS BY SYNTAXIN 4 ENRICHMENT

#1297
20200399333
2020-12-24

Histatins and method of use thereof

#1298
20200397864
2020-12-24

TREATING ROTATOR CUFF CONDITIONS

#1299
20200397860
2020-12-24

SLIT AND BONE GROWTH MODULATION

#1300
20200397859
2020-12-24

Reconstituted HDL formulation

#1301
20200397858
2020-12-24

Compositions and methods for modulation of immune response

#1302
20200397832
2020-12-24

Method and system for reducing the likelihood of developing depression in an individual

#1303
20200397690
2020-12-24

THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c

#1304
20200393448
2020-12-17

THE VOLUME-REGULATED ANION CHANNEL PROTEIN LRRC8A FOR USE IN ALTERING EPIDERMAL KERATINOCYTE DIFFERENTIATION

#1305
20200392492
2020-12-17

Modulating Immune Responses

#1306
20200390907
2020-12-17

METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE

#1307
20200390885
2020-12-17

Methods for enhancing antigen-specific immune responses

#1308
20200390857
2020-12-17

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

#1309
20200390853
2020-12-17

Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof

#1310
20200390818
2020-12-17

METHODS USING WHEY PROTEIN TO IMPROVE OR MAINTAIN MUSCLE QUALITY

#1311
20200385485
2020-12-10

PROLIFERATION OF MUC1 EXPRESSING CELLS

#1312
20200385464
2020-12-10

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

#1313
20200385439
2020-12-10

Immunoglobulins and uses thereof

#1314
20200384076
2020-12-10

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

#1315
20200384075
2020-12-10

Compositions and methods for enhancing neuro-repair

#1316
20200384074
2020-12-10

Therapeutic agent for inflammatory bowel disease

#1317
20200384073
2020-12-10

MODIFIED FRIEDREICH ATAXIA GENES AND VECTORS FOR GENE THERAPY

#1318
20200384072
2020-12-10

THERAPY OF IONIZING RADIATION-INDUCED DISORDERS

#1319
20200384070
2020-12-10

Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases

#1320
20200377586
2020-12-03

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

#1321
20200377566
2020-12-03

Modified ligand-gated ion channels and methods of use

#1322
20200376141
2020-12-03

Optimized mini-dystrophin genes and expression cassettes and their use

#1323
20200376138
2020-12-03

LIPID NANO PARTICLE COMPLEX COMPRISING APTIDE FUSED WITH CELL PENETRATING MATERIALS AND USE SAME

#1324
20200376095
2020-12-03

MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES

#1325
20200376078
2020-12-03

Compositions of phosphorylated tau peptides and uses thereof

#1326
20200376040
2020-12-03

USE OF CEREBROLYSIN

#1327
20200376028
2020-12-03

Methods and Compounds for Treating Diabetes

#1328
20200370069
2020-11-26

TREATMENT OF SPINAL MUSCULAR ATROPHY

#1329
20200369750
2020-11-26

HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION

#1330
20200368266
2020-11-26

Compositions and methods using a polyphenol for musculoskeletal health

#1331
20200360472
2020-11-19

Compositions and methods for treating motor neuron diseases

#1332
20200360267
2020-11-19

THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c

#1333
20200353377
2020-11-12

Extraction of animal-derived pulmonary surfactants

#1334
20200353040
2020-11-12

Pharmaceutical Composition Comprising an APL Type Peptide

#1335
20200353039
2020-11-12

Prevention and/or treatment of hearing loss or impairment

#1336
20200353038
2020-11-12

PIF-TRANSFECTED CELLS AND METHODS OF USE

#1337
20200353031
2020-11-12

COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS USING AN ENDOTHELIN-B RECEPTOR AGONIST

#1338
20200353007
2020-11-12

Pharmacological Composition for Prevention or Treatment of Lupus, Comprising Mesenchymal Stem Cell-Derived Secretome

#1339
20200352859
2020-11-12

Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal

#1340
20200345957
2020-11-05

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

#1341
20200345902
2020-11-05

Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods

#1342
20200345851
2020-11-05

EPICARDIAL-DERIVED PARACRINE FACTORS FOR REPAIRING CARDIAC TISSUE

#1343
20200345821
2020-11-05

Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors

#1344
20200345815
2020-11-05

Type I diabetes therapy

#1345
20200345813
2020-11-05

Compositions and methods for the systemic treatment of arthritis

#1346
20200345811
2020-11-05

Methods and compositions for modulating myofibroblast activities

#1347
20200345809
2020-11-05

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#1348
20200339642
2020-10-29

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#1349
20200338176
2020-10-29

METHODS AND COMPOSITIONS RELATING TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER

#1350
20200338162
2020-10-29

EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE

#1351
20200338161
2020-10-29

BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies

#1352
20200338160
2020-10-29

Methods and compositions for regenerating hair cells and/or supporting cells

#1353
20200338030
2020-10-29

Sensorineural hair cell differentiation

#1354
20200330648
2020-10-22

Implants having a drug load of an oxysterol and methods of use

#1355
20200330592
2020-10-22

COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S AND OTHER AMYLOID RELATED DISEASES

#1356
20200330554
2020-10-22

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#1357
20200330552
2020-10-22

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1358
20200330550
2020-10-22

METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP)

#1359
20200330526
2020-10-22

Method for reducing the likelihood of developing cancer in an individual human being

#1360
20200325452
2020-10-15

Processes for making and using a mesenchymal stem cell derived secretome

#1361
20200325190
2020-10-15

Modification and Compositions of Human Secretoglobin Proteins

#1362
20200323954
2020-10-15

METHODS AND COMPOSITIONS FOR REDUCING GUT ISCHEMIA/REPERFUSION-INDUCED INJURY

#1363
20200323953
2020-10-15

Immunosuppressive agents and their use in therapy

#1364
20200323952
2020-10-15

COMPOSITIONS AND METHODS OF TREATING CANCER

#1365
20200323947
2020-10-15

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#1366
20200316170
2020-10-08

Compositions and methods for the treatment of malnutrition

#1367
20200316169
2020-10-08

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

#1368
20200316168
2020-10-08

INHIBITORS OF IGFBP3 BINDING TO TMEM219 FOR TREATMENT OF INTESTINAL DISEASES

#1369
20200316073
2020-10-08

Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection

#1370
20200308237
2020-10-01

Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target

#1371
20200308236
2020-10-01

Stapled intracellular-targeting antimicrobial peptides to treat infection

#1372
20200306343
2020-10-01

TREATMENT OF AN ISCHEMIC HEART DISEASE

#1373
20200306342
2020-10-01

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

#1374
20200306341
2020-10-01

TREATMENT OF EYE DISEASE

#1375
20200306316
2020-10-01

Methods and compositions relating to chondrisomes from blood products

#1376
20200306315
2020-10-01

Methods and compositions relating to chondrisomes from cultured cells

#1377
20200299348
2020-09-24

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

#1378
20200297801
2020-09-24

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1379
20200297800
2020-09-24

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

#1380
20200297775
2020-09-24

ENHANCED DIRECT CARDIAC REPROGRAMMING

#1381
20200291100
2020-09-17

TREATMENT OF AGE-RELATED AND MITOCHONDRIAL DISEASES BY INHIBITION OF HIF-1 ALPHA FUNCTION

#1382
20200289670
2020-09-17

RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

#1383
20200289617
2020-09-17

Method for preparing a bone protein preparation and a bone protein preparation

#1384
20200289615
2020-09-17

Compositions for treating heart disease by inhibiting the action of mAKAPβ

#1385
20200289560
2020-09-17

Combined preparations of PKM2 modulators and HMGB1

#1386
20200289416
2020-09-17

Drug delivery vehicles for atherosclerosis nanomedicine

#1387
20200283538
2020-09-10

Targeted protein degradation

#1388
20200283491
2020-09-10

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

#1389
20200282017
2020-09-10

Compositions and method for reducing virulence of microorganisms

#1390
20200282005
2020-09-10

Adhesion prevention material

#1391
20200281961
2020-09-10

GLUCOCEREBROSIDE TREATMENT OF DISEASE

#1392
20200277611
2020-09-03

PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY

#1393
20200276284
2020-09-03

Methods for treatment of and prophylaxis against inflammatory disorders

#1394
20200276266
2020-09-03

SRPX for treatment of cancer

#1395
20200276122
2020-09-03

Hydrogel toxin-absorbing or binding nanoparticles

#1396
20200271665
2020-08-27

DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA

#1397
20200270695
2020-08-27

MECP2E1 GENE

#1398
20200270692
2020-08-27

PREDICTING AGE-RELATED MACULAR DEGENERATION WITH SINGLE NUCLEOTIDE POLYMORPHISMS WITHIN OR NEAR THE GENES FOR COMPLEMENT COMPONENT C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

#1399
20200270337
2020-08-27

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

#1400
20200268863
2020-08-27

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1401
20200268839
2020-08-27

COMPOSITION FOR TREATING PULMONARY FIBROSIS AND EMPHYSEMA AND THERAPEUTIC METHOD USING THE SAME

#1402
20200268838
2020-08-27

NORRIN INDUCED EXPRESSION OF GENES AND USE THEREOF TO TREAT DISEASE

#1403
20200268806
2020-08-27

Therapeutic compositions

#1404
20200262866
2020-08-20

Process of manufacture of annexin V

#1405
20200261556
2020-08-20

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

#1406
20200261547
2020-08-20

CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D

#1407
20200261412
2020-08-20

Use of actin depolymerizing agents for the treatment of anxiety disorders

#1408
20200261389
2020-08-20

PROTECTIVE METALLOTHIONEIN ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES

#1409
20200255495
2020-08-13

ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS

#1410
20200255446
2020-08-13

Compositions and methods for treating cancer

#1411
20200254076
2020-08-13

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy

#1412
20200254060
2020-08-13

Compositions and methods for delivering CFTR polypeptides

#1413
20200254059
2020-08-13

THERAPEUTIC AGENT OF UREMIA CONTAINING ALARIN AS THE MAIN INGREDIENT

#1414
20200254055
2020-08-13

Pharmaceutical compositions and preparations for administration to the eye

#1415
20200247884
2020-08-06

Oligonucleotides for reduction of PD-L1 expression

#1416
20200247880
2020-08-06

Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies

#1417
20200246509
2020-08-06

IMPLANTS HAVING A HIGH DRUG LOAD OF AN OXYSTEROL AND METHODS OF USE

#1418
20200246434
2020-08-06

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

#1419
20200246433
2020-08-06

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

#1420
20200246429
2020-08-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

#1421
20200246425
2020-08-06

Treatments of Metabolic Disorders Using FGF Binding Protein 3

#1422
20200246424
2020-08-06

PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION

#1423
20200239543
2020-07-30

Constructs having a SIRP-α domain or variant thereof

#1424
20200237873
2020-07-30

Systems and methods for angiogenic treatment in wound healing

#1425
20200237867
2020-07-30

METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION

#1426
20200237863
2020-07-30

Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors

#1427
20200237861
2020-07-30

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#1428
20200237860
2020-07-30

Hsp70 based combination therapy

#1429
20200237652
2020-07-30

HEMOPEXIN FORMULATIONS

#1430
20200230218
2020-07-23

Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein

#1431
20200230201
2020-07-23

Peptide inhibitors of twist

#1432
20200230090
2020-07-23

Treatment and diagnosis of melanoma

#1433
20200225240
2020-07-16

USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT

#1434
20200224272
2020-07-16

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

#1435
20200222501
2020-07-16

PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION

#1436
20200222500
2020-07-16

Methods and compositions for modulating appetite and intake of sodium

#1437
20200222499
2020-07-16

Compositions and methods for treating diabetes, hypertension and hypercholesterolemia

#1438
20200222492
2020-07-16

Method of Reducing Injury to Mammalian Cells

#1439
20200222322
2020-07-16

Phosphoserine containing compositions for immune tolerance induction

#1440
20200215209
2020-07-09

Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders

#1441
20200215157
2020-07-09

Composition and methods for treatment of primary ciliary dyskinesia

#1442
20200215156
2020-07-09

Compositions and methods for inhibiting intercellular interactions

#1443
20200215120
2020-07-09

EXOSOMES AND METHODS OF USE THEREOF

#1444
20200214309
2020-07-09

Anti-reflux infant nutrition

#1445
20200209239
2020-07-02

PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

#1446
20200206315
2020-07-02

Compositions and methods comprising bone morphogenetic protein and NEMO binding peptide

#1447
20200206308
2020-07-02

Suppression of allergic lung inflammation and hyperreactivity

#1448
20200199621
2020-06-25

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

#1449
20200199186
2020-06-25

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

#1450
20200199184
2020-06-25

Methods and compositions for regenerating tissues

#1451
20200197486
2020-06-25

Complexes for treating sensitivity

#1452
20200190162
2020-06-18

Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

#1453
20200188481
2020-06-18

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

#1454
20200181224
2020-06-11

Recombinant klotho proteins and compositions and methods involving same

#1455
20200181218
2020-06-11

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#1456
20200181217
2020-06-11

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#1457
20200181215
2020-06-11

Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

#1458
20200179485
2020-06-11

Beta-casein A2 and prevention of inflammation of the bowel

#1459
20200179484
2020-06-11

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANNEXIN A5

#1460
20200179483
2020-06-11

Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions

#1461
20200179482
2020-06-11

COMPOSITION FOR AND METHOD OF FACILITATING CORNEAL TISSUE REPAIR

#1462
20200179460
2020-06-11

Reducing the likelihood of skin cancer in an individual human being

#1463
20200174023
2020-06-04

Neuronal viability factor and use thereof in Alzheimer's disease

#1464
20200174017
2020-06-04

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#1465
20200174016
2020-06-04

MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY

#1466
20200172574
2020-06-04

INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION

#1467
20200171127
2020-06-04

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES

#1468
20200171126
2020-06-04

Reconstituted high density lipoprotein formulation and production method thereof

#1469
20200171092
2020-06-04

THERAPEUTIC AGENT FOR DILATED CARDIOMYOPATHY

#1470
20200165691
2020-05-28

Methods for inducing cell division of postmitotic cells

#1471
20200165681
2020-05-28

GENES AND POLYMORPHISMS ASSOCIATED WITH AGE RELATED MACULAR DEGENERATION (AMD)

#1472
20200164053
2020-05-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1473
20200163998
2020-05-28

NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS

#1474
20200163885
2020-05-28

COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL

#1475
20200155691
2020-05-21

Ice-based lipid nanoparticle formulation for delivery of mRNA

#1476
20200155675
2020-05-21

METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION

#1477
20200155645
2020-05-21

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1478
20200155571
2020-05-21

Topically Active Steroids for Use in Radiation and Chemotherapeutics Injury

#1479
20200148743
2020-05-14

HLA-G transcripts and isoforms and their uses

#1480
20200147267
2020-05-14

Enhancement of osteogenic potential of bone grafts

#1481
20200147184
2020-05-14

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

#1482
20200147173
2020-05-14

BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE

#1483
20200147172
2020-05-14

USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES

#1484
20200141922
2020-05-07

Flattop (fltp) is a novel biomarker for beta cell maturation

#1485
20200140522
2020-05-07

ApoC-II mimetic peptides

#1486
20200140502
2020-05-07

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

#1487
20200140501
2020-05-07

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

#1488
20200140488
2020-05-07

ALZHEIMER'S DISEASE TREATMENT METHOD

#1489
20200140405
2020-05-07

Compositions comprising an urolithin compound

#1490
20200139162
2020-05-07

Method of inducing cardiomyocytes proliferation and treating heart diseases

#1491
20200138903
2020-05-07

SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES

#1492
20200138902
2020-05-07

Clusterin for use in the treatment of thrombotic microangiopathies

#1493
20200131237
2020-04-30

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

#1494
20200131236
2020-04-30

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1

#1495
20200129629
2020-04-30

Glycotargeting therapeutics

#1496
20200129590
2020-04-30

BETA-CASEIN A2 AND BLOOD GLUCOSE LEVELS

#1497
20200129588
2020-04-30

Method of treating knee pain

#1498
20200129581
2020-04-30

Pharmaceutical composition containing ATPIF1 for treatment of diabetes

#1499
20200129557
2020-04-30

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

#1500
20200129535
2020-04-30

DESMOCOLLIN 1 INHIBITORS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS